These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11994435)

  • 1. Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy.
    Derre L; Corvaisier M; Pandolfino MC; Diez E; Jotereau F; Gervois N
    J Immunol; 2002 May; 168(10):4864-70. PubMed ID: 11994435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
    Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes.
    Van Beneden K; De Creus A; Stevenaert F; Debacker V; Plum J; Leclercq G
    J Immunol; 2002 Apr; 168(7):3295-302. PubMed ID: 11907085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD94/NKG2 expression does not inhibit cytotoxic function of lymphocytic choriomeningitis virus-specific CD8+ T cells.
    Miller JD; Peters M; Oran AE; Beresford GW; Harrington L; Boss JM; Altman JD
    J Immunol; 2002 Jul; 169(2):693-701. PubMed ID: 12097371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells.
    Van Beneden K; Stevenaert F; De Creus A; Debacker V; De Boever J; Plum J; Leclercq G
    J Immunol; 2001 Apr; 166(7):4302-11. PubMed ID: 11254682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
    Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
    J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
    Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
    J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
    Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
    Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma.
    Vetter CS; Straten PT; Terheyden P; Zeuthen J; Bröcker EB; Becker JC
    J Invest Dermatol; 2000 May; 114(5):941-7. PubMed ID: 10771475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro.
    Lian RH; Maeda M; Lohwasser S; Delcommenne M; Nakano T; Vance RE; Raulet DH; Takei F
    J Immunol; 2002 May; 168(10):4980-7. PubMed ID: 11994449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential survival of CD8 T and NK cells expressing high levels of CD94.
    Gunturi A; Berg RE; Forman J
    J Immunol; 2003 Feb; 170(4):1737-45. PubMed ID: 12574337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer.
    Bellón T; Heredia AB; Llano M; Minguela A; Rodriguez A; López-Botet M; Aparicio P
    J Immunol; 1999 Apr; 162(7):3996-4002. PubMed ID: 10201920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells.
    McMahon CW; Zajac AJ; Jamieson AM; Corral L; Hammer GE; Ahmed R; Raulet DH
    J Immunol; 2002 Aug; 169(3):1444-52. PubMed ID: 12133970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of inhibitory and activating CD94/NKG2 receptors on NK cell clones.
    Brostjan C; Bellón T; Sobanov Y; López-Botet M; Hofer E
    J Immunol Methods; 2002 Jun; 264(1-2):109-19. PubMed ID: 12191515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway.
    Zeddou M; Greimers R; de Valensart N; Nayjib B; Tasken K; Boniver J; Moutschen M; Rahmouni S
    Biochem Pharmacol; 2005 Sep; 70(5):714-24. PubMed ID: 15978547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2.
    Fraser KP; Gays F; Robinson JH; van Beneden K; Leclercq G; Vance RE; Raulet DH; Brooks CG
    Eur J Immunol; 2002 Mar; 32(3):868-78. PubMed ID: 11870631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD94 and NKG2 molecules on human CD4(+) T cells in response to CD3-mediated stimulation.
    Romero P; Ortega C; Palma A; Molina IJ; Peña J; Santamaría M
    J Leukoc Biol; 2001 Aug; 70(2):219-24. PubMed ID: 11493613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene.
    Cantoni C; Biassoni R; Pende D; Sivori S; Accame L; Pareti L; Semenzato G; Moretta L; Moretta A; Bottino C
    Eur J Immunol; 1998 Jan; 28(1):327-38. PubMed ID: 9485212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.